STVN STEVANATO GRP SPA

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

PIOMBINO DESE, Italy--(BUSINESS WIRE)--

(NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the KeyBanc Capital Markets Healthcare Forum taking place from Tuesday, March 18 to Wednesday, March 19, 2025.

The Company will present on Tuesday, March 18, at 3.00 p.m. (ET). A live webcast will be available on the Company’s website at under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value-added solutions to clients.

For more information, please visit: .

EN
11/03/2025

Underlying

STVNSTEVANATO GRP SPA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STEVANATO GRP SPA

 PRESS RELEASE
Free
STVN STEVANATO GRP S...

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual ...

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the KeyBanc Capital Markets Healthcare Forum taking place from Tuesday, March 18 to Wednesday, March 19, 2025. The Company will present on Tuesday, March 18, at 3.00 p.m. (ET). A live webcast will be available on the Company’s website at under the "Investors" section. A replay of the webcast will be available for approximately 90 days after t...

March 11, 2025 1 EN
 PRESS RELEASE
Free
STVN STEVANATO GRP S...

Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Ye...

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter and fiscal year 2024. Fourth Quarter and Full-Year 2024 Highlights (comparisons to prior-year period) Revenue for the fourth quarter of 2024 increased 3% to €330.6 million, and high-value solutions represented 40% of total revenue, in line with Company expectations. For the fourth quarter, diluted ear...

March 6, 2025 1 EN
 PRESS RELEASE
Free
STVN STEVANATO GRP S...

Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financia...

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the fourth quarter and fiscal year 2024 on Thursday, March 6, 2025, at 6:30 a.m.(ET). Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Thursday, March 6, 2025, to discuss financial results. During the call, management will refer to a slide presentation that...

February 24, 2025 1 EN
Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 290.00
GLW CORNING INC
GXI GERRESHEIMER AG ... (+3)

Sondierungsgespräche mit Private Equity – GXI in Transition

Mit Private Equity Investoren hätten lt. CN v 07.02.25 auf informeller und unverbindlicher Basis ihr „Interesse an einem möglichen öffentlichen Übernahmeangebot bekundet“. Interesse von Finanzinvestoren gab es bereits in der Vergangenheit. GXI ist in einer Übergangsphase, zumal die Bormioli-Integration andauert. Seit der Gewinnwarnung im 09/24 hatte sich der Aktienkurs fast halbiert.

GLW CORNING INC
GXI GERRESHEIMER AG
STVN STEVANATO GRP SPA
02/10/25 February 10, 2025 4 DE
Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 290.00
GLW CORNING INC
GXI GERRESHEIMER AG ... (+3)

Exploratory talks with private equity – GXI in transition

According to CN 07.02.25, private equity investors have expressed ‘interest in a potential public takeover offer’ on an informal and non-binding basis. GXI is in a transition phase, especially as the Bormioli integration is ongoing. There has been interest from financial investors in the past. Since the profit warning on 09/24, the share price has almost halved.

GLW CORNING INC
GXI GERRESHEIMER AG
STVN STEVANATO GRP SPA
02/10/25 February 10, 2025 4 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch